Walker Marlan D

Chief Executive Officer at TXMD

Sold, on record
$76k
Dollars the filings state
Form 4 sales
4
Latest Dec 7, 2023
Form 144 notices
1
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • TXMDTherapeuticsMD, Inc.Chief Executive Officer

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale TXMDUnusual
    May 11 2021

    Sold 21,592 shares at $1.04 ($22k)

    Walker Marlan D, General Counsel

    Sold 42.8% of holdings ($53k position)28,908 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale TXMDPlan not stated
    Dec 6 +574 days

    Sold 1,048 shares at $4.95 ($5k)

    Walker Marlan D, General Counsel

    Sold 13.6% of holdings ($38k position)6,685 shares leftFiling

  3. 3 Form 4 sale TXMDNo plan
    Apr 12 +127 days

    Sold 1,170 shares at $3.65 ($4k)

    Walker Marlan D, Chief Executive Officer

    No 10b5-1 planSold 8.7% of holdings ($49k position)12,307 shares leftFiling

  4. 4 Form 144 notice TXMDNotice
    Dec 6 +238 days

    Filed to sell 28,134 shares ($70k)

    Walker Marlan D, Officer

    No 10b5-1 planFiling

  5. 5 Form 4 sale TXMDNo plan
    Dec 7 +1 day

    Sold 19,050 shares at $2.29 ($44k)

    Walker Marlan D, Chief Executive Officer

    No 10b5-1 planSold 23.3% of holdings ($187k position)62,565 shares leftFollows a Form 144Filing

Every transaction

Loading transactions…

Sales and notices (5)

Form 144 notices and Form 4 sales by Walker Marlan D
Source
Dec 7, 2023TXMDChief Executive OfficerForm 4 sale19,050$44k23.3%No planSEC
Dec 6, 2023TXMDOfficerForm 144 notice28,134$70kNoticeSEC
Apr 12, 2023TXMDChief Executive OfficerForm 4 sale1,170$4k8.7%No planSEC
Dec 6, 2022TXMDGeneral CounselForm 4 sale1,048$5k13.6%Plan not statedSEC
May 11, 2021TXMDGeneral CounselForm 4 sale21,592$22k42.8%UnusualSEC